Cost Effectiveness of Different Platelet Preparation, Storage, Selection and Dosing Methods in Platelet Transfusion: A Systematic Review. [PDF]
Laermans J+10 more
europepmc +1 more source
When to give platelet transfusions [letter; comment] [PDF]
EJ Freireich
openalex +1 more source
Current Practice Regarding Bleeding Disorders of Unknown Cause in the Netherlands: A National Survey
ABSTRACT Introduction About 40%–70% of persons with a clinically relevant bleeding tendency who are referred to haemostasis experts are classified as having a ‘bleeding disorder of unknown cause’ (BDUC) as no biological entity can be found after extensive laboratory testing.
Caroline M. A. Mussert+15 more
wiley +1 more source
Is there a need for fresh frozen plasma and platelet transfusion in trauma patients receiving submassive transfusion? [PDF]
Jehan F+6 more
europepmc +1 more source
ABSTRACT Background Endogenous endophthalmitis is an infrequent yet severe complication of hemodialysis catheter‐related sepsis. In this report, we present a case of endogenous bacterial endophthalmitis in a patient with hemodialysis catheter‐related sepsis.
Hui Guo+5 more
wiley +1 more source
Existence and significance of anti-HLA-C autoantibodies to primary and persistent platelet transfusion refractoriness in patients with hematologic disorders: a retrospective study from a single centre. [PDF]
Li X+17 more
europepmc +1 more source
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani+2 more
wiley +1 more source
Platelet HLA gene bank digital matching technology for platelet transfusion refractory patients with malignant tumors: a case report. [PDF]
Gao X, Li J, Ni X, Wang L, Hu P, Zhu X.
europepmc +1 more source
ABSTRACT Introduction Acute leukemias with hyperleukocytosis (> 100 × 109/L) can produce cytoplasmic blast fragments that interfere with platelet counts, notably in impedance‐based methods, potentially masking severe thrombocytopenia and increasing hemorrhagic risk.
Victor Bobée+10 more
wiley +1 more source